Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

By Gregg Stone, A. Rizvi, W. Newman, Kourosh Mastali, John Wang, R. Caputo, Julie Doostzadeh, Sherry Cao, C. Simonton, K. Sudhir and 3 more. New England Journal of Medicine, 2010

901 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/bfb9f5f714c0835062beeb46bfa3739948e9a197

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. W. Wijns
2. Philippe Kolh
3. Nicolas Danchin
4. C. Di Mario
5. Nicolaus Reifart
6. Volkmar Falk
7. S. Silber
8. J. L. Pomar

Citations in the corpus

• Guidelines on myocardial revascularization. (2010, background): “8%) [225].”
• Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the society for cardiovascular angiography and interventions (SCAI) (2014, neutral): “7% of stented patients, respectively; there was no relationship between any level of either biomarker and 2-year mortality, even >10 ULN (27).”